Publications found:
400
Sort by:
Adalimumab Market - 2024-2031
US$ 3,400.00
Adalimumab Marketis is growing with a CAGR of 5.20% during the forecast period 2026-2035. The Adalimumab Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned re...
September 2024
36 pages
Interferons Market - 2024-2031
US$ 3,400.00
The Interferons Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
June 2024
37 pages
Recombinant Plasma Protein Therapeutics Market - 2024-2031
US$ 3,400.00
Recombinant Plasma Protein Therapeutics Marketis is growing with a CAGR of 6.20% during the forecast period 2026-2035. The Recombinant Plasma Protein Therapeutics Market emerges as a key focus in Data...
June 2024
65 pages
Inter-alpha-inhibitor Proteins Market - 2024-2031
US$ 3,400.00
The Inter-alpha-inhibitor Proteins Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...
April 2024
56 pages
Interferon Drugs Market - 2024-2031
US$ 3,400.00
Interferon Drugs Marketis is growing with a CAGR of 4.00% during the forecast period 2026-2035. The Interferon Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where...
February 2024
42 pages
Blood Plasma Derivatives Market - 2024-2031
US$ 3,400.00
Blood Plasma Derivatives Marketis is growing with a CAGR of 4.30% during the forecast period 2026-2035. The Blood Plasma Derivatives Market emerges as a key focus in DataM Intelligence latest in-depth...
January 2024
50 pages
Plasma Protein Therapeutics Market - 2024-2031
US$ 3,400.00
The Plasma Protein Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...
January 2024
53 pages
Systemic Juvenile Idiopathic Arthritis Market - 2024-2031
US$ 3,400.00
Systemic Juvenile Idiopathic Arthritis Marketis is growing with a CAGR of 4.10% during the forecast period 2026-2035. The Systemic Juvenile Idiopathic Arthritis Market emerges as a key focus in DataM...
October 2023
64 pages
Lyophilized Antivenins Market - 2024-2031
US$ 3,400.00
The Lyophilized Antivenins Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver u...
October 2023
48 pages
Global CAR T Cell Therapy Market & Clinical Trials Insight 2028
US$ 3,000.00
... CAR T Cell Therapies Clinical Pipeline by Company, Indication & Phase Global CAR T Cell Therapies Clinical Pipeline: 99 Therapies CAR T Cell Therapies in Highest Phase: Preregistration Majority of CAR T Cell Therapies in Phase-I/II Trials: 16 Therapies Global Market Scenario of CAR T Cell Therapy Global CAR ...
May 2022
720 pages
Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026
US$ 2,800.00
... Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 Cell Therapy Clinical Trial Insight by Indication, Company & Country Global Cell Therapy Clinical Pipeline: 767 Cell Therapies Globally Marketed Cell Therapies: 25 Cell Therapies Maximum Number of Marketed Cell Therapies In USA: 15 Therapies ...
April 2019
1200 pages
Global CAR T Cell Therapy Market Opportunity & Clinical Pipeline Insight 2024
US$ 2,800.00
... Cell Therapies Clinical Pipeline by Company, Indication & Phase: 236 Therapies CAR-T Cell Therapies in Highest Phase: Preclinical Marketed CAR-T Cell Therapies: 2 ( Yescarta & Kymriah) Global Market Scenario of CAR T Cell Therapy Global CAR T Cell Therapy Market Future Prospects The research in immunotherapy ...
November 2018
400 pages
Global Cell Therapy Market & Clinical Pipeline Outlook 2022
US$ 2,400.00
... 2022” Highlights: Introduction & Classification of Cell Therapies Mechanism of Cell Therapy Global Cell Therapy Market Analysis Role of Stem Cells in Cell Therapy Global Cell Therapy Clinical Pipeline by Country, Indication & Phase Global Cell Therapy Clinical Pipeline: 476 Marketed Cell Therapies: 20
November 2016
850 pages
Global Bispecific Antibody Market & Clinical Pipeline Insight 2020
US$ 2,400.00
... Bispecific Antibody Design & Engineering of Bispecific Antibodies Applications of Bispecific Antibodies Global Bispecific Antibodies Clinical Pipeline by Company, Indication & Phase Global Bispecific Antibodies Clinical Pipeline: 123 Bispecific Antibodies Marketed Bispecific Antibodies ...
July 2016
213 pages
Global Cell Therapy Market Outlook 2020
US$ 2,400.00
... of Stem Cells in Cell Therapy Global Cell Therapy Market Analysis Global Cell Therapy Clinical Pipeline by Country, Indication & Phase Marketed Cell Therapy Clinical Insight by Brand Name, Company & Indication Global Cell Therapy Clinical Pipeline: 262 Cell Therapies Marketed Cell Therapies: 13 Marketed Cell ...
May 2015
550 pages
Global Gene Therapy Market & Pipeline Insight
US$ 2,400.00
... Gene Therapy to Cancer Treatment Gene Therapy Market Dynamics: Drivers, Challenges & Future Outlook FDA & AMA Guidelines for Gene Therapy Gene Therapy Pipeline by Phase, Indications, Country & Company Gene Therapy Pipeline: 246 Drugs Marketed Gene Therapy: 2 (Gendicine & Rexin-G) Cancer Gene Therapy Pipeline ...
October 2014
949 pages
Recombinant Therapeutic Proteins Market & Pipeline Analysis
US$ 2,400.00
... . “Recombinant Therapeutic Proteins Market & Pipeline Analysis” Report Highlights: Global Market Overview Mechanisms of Recombinant Protein Production Types of Recombinant DNA Technology Clinical Pipeline by Phase, Indication, Company, & Country Marketed Recombinant Therapeutic Protein Drugs ...
September 2014
899 pages
Cancer Cell Therapy Market & Pipeline Insight
US$ 2,400.00
... the spread of cancer. “Cancer Cell Therapy Market & Pipeline Insight” Report Highlights & Findings: Cancer Cell Therapy Market Overview Cancer Cell Therapy Market Dynamics Clinical Pipeline by Phase, country & Target Indications Cancer Cell Therapy Drugs in Pipeline: 82 Highest Number of Drugs in Preclinical ...
June 2014
195 pages
Antibody Drug Conjugate Market Opportunity Analysis
US$ 2,200.00
... and market value in the years to come. The Antibody Drug Conjugates market will definitely witness an increase in the partnership and collaborative agreements to develop these drugs. It has ... source of knowledge. “Antibody Drug Conjugate Market Opportunity Analysis” Report Highlights: Global ADC Market Insight ADC Patent Analysis Orphan Status & ADC Favorable Market Drivers & Key Issues ...
May 2014
350 pages
Global Cell Therapy Market & Pipleine Insight
US$ 2,400.00
... threatening diseases. “Global Cell Therapy Market & Pipeline Insight” Report Highlights & Findings: Introduction to Cell therapy Global Cell Therapy Market Overview Global Cell Therapy Market Dynamics Cell Therapy Pipeline by Phase, Country & Target Indications Cell Therapy Drugs in Pipeline: More ...
March 2014
500 pages